E.g., 29-11-2021
E.g., 29-11-2021
We have found 231 results.
View by: Grid List
Sort by: Relevancy Date
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    A Conservative But Costly Plan

    A major concern of negotiators and activists at this month’s global climate meetings is the size and credibility of China’s decarbonization commitment. However, as Arthur and Rosealea explain there are good reasons to believe that climate goals will play a large role in China’s policy mix in the coming decade—with large risks to economic growth.

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Decarbonization’s Disruptions

    Media attention at this month’s COP26 climate talks in Glasgow will focus on which promises governments make to combat climate change. Yet this distracts from the substantive questions the world will need to grapple with in the next several years as the promised energy transition moves into gear.

    9
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Irresistible Force Vs. Immovable Object, Round Two

    US policy on China is now defined by an acute tension between national security and business interests. In this report, Arthur and Dan explain how the Biden administration is navigating this tension, one which will be a permanent feature of the global landscape over the next decade.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    The Taiwan Risk

    With the hardening of the US-China strategic rivalry and technology’s central role in that rivalry, the possibility of a war over Taiwan is one which must be considered. In this report, Arthur explains the importance of the island to both countries and concludes that while the risk of war remains low, it is likely to rise in the next several years.

    8
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    What Strategic Competition Looks Like

    Last week’s diplomatic meeting between China and the US was marked by harsh rhetoric as both sides used the event to signal toughness to their home audiences. In this report, Arthur and Dan outline what policy tools Beijing and Washington have at their disposal and why the Biden administration is struggling to articulate a clear China strategy.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Vaccines, Efficacy And Variants

    Despite volumes of new information and the lightning creation of vaccines promising a path out of the pandemic, uncertainty remains. Almost daily we are bombarded with a mix of good news (the vaccines work really well!) and bad (new mutations resist vaccines!) that make it hard to know whether we should rejoice or despair. This note provides a framework for assessing these persistent uncertainties.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    Fine-Tuning The US-China Rivalry

    In almost no area of the US-China relationship can President-elect Biden fully reverse the combative approach President Trump has put in place. Instead, writes Arthur, the Biden administration will likely fine-tune regulations to balance US economic and security interests, all while working closer with US allies—none of which will be easy.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    Hawks In The Driver’s Seat

    The China hawks are at the wheel in the Trump administration and driving as fast as they can. In this report, Arthur outlines the many tactics being employed by hardliners in the White House to lock in an adversarial stance against China ahead of the US elections. However tense things have been so far, even tenser times lie ahead.

    3
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A Long Autumn For Covid In The US

    Covid-19 has largely gone into the rear-view mirror in East Asia, and has been tamped down in Europe, but keeps dominating the headlines in the US. Infections in the current US wave are likely to peak in the first half of August, while deaths will peak in late August or early September. Recovery in sectors with high levels of human contact will continue to be retarded through the summer. About one-eighth of GDP, and a quarter of the workforce,...

    4
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    US Regional Outbreaks Hit A Key Threshold

    The southern United States is in the grip of a major wave of the Covid-19 pandemic. Until now, Arthur has taken the view that rising case numbers alone would not be enough to convince state governments to slow down or roll back economic reopening plans. However, the risks to this core scenario are mounting.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    US Reopening Tested By Regional Covid Outbreaks

    Many US states begun to re-open their economies without getting their Covid-19 outbreaks firmly under control. They initially did this without experiencing a spike in infection levels, but the situation has now changed, writes Arthur. The question is whether this new wave of the epidemic proves severe enough to compel states to roll back economic reopening.

    4
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    US Reopens Without A Covid Spike—So Far

    As the US moves to reopen its economy from Covid-19 lockdowns, a key question is whether these reopenings will engender a resurgence of the epidemic, thereby retarding the pace of economic recovery. The risk cannot be ruled out, and the large uncertainties about how the coronavirus works means we should be wary of definitive forecasts. Yet so far, about a month after the initial reopenings, there is not much evidence of a resurgence.

    0
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    Some Details On The Shape Of Things To Come

    On Monday, Arthur laid out the core scenario for the exit from social lockdowns in both Europe and the US: a gradual relaxation of the most severe restrictions between now and mid-June, followed by several months or more of significant, but less onerous, restrictions. In this piece he offers more detail on how things might play out in individual countries and states.

    6
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    The Shape Of Things To Come

    As the US and Europe prepare to enter their second month of lockdown, the good news is that social controls, where they are imposed, are working. The less good news is that the exit from lockdowns is going to be long and arduous. It is likely that in most major Western nations, economic activity will remain at levels significantly below normal until well into the fall.

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    A Poor Prognosis For US-China Ties

    The Covid-19 pandemic has been bad for the health of the US-China relationship, which was already in poor shape. In this piece, Arthur explains how US security hawks have seized the opportunity to hammer home the argument that China is untrustworthy, pushing the US debate over China policy in a more confrontational direction.

    2
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    How Long For The Costly Cure?

    Is the cure worse than the disease? This question is already being asked about the economic lockdowns being imposed in response to Covid-19. It will be asked a lot more in the coming weeks as the economic pain gets worse. The short answer is that the cure is costly, but needed; and well-designed policies can enable a transition to a much lower-cost approach by mid-May if not earlier.

    7
  • Please login, request a trial or contact our sales team for more information

    Gavekal Research

    A Bad Prognosis

    The US and Europe are moving towards Hubei-style societal lockdowns. Arthur sifts through the latest epidemiological research, and concludes that while the worst case public health scenarios will be avoided, the coming lockdowns will be severe and last long enough to have an economic impact possibly more damaging than in China.

    6
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    The Long And Short Of Covid-19

    There is now enough information available to begin to make useful judgments about both the short term and long term impact of the Covid-19 outbreak. In this extensive analysis, Arthur examines the health risks posed by the virus, its economic impact, and likely political fallout.

    5
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    From Trade War To Decoupling

    Trade talks between the US and China will resume this week after a three-month hiatus, but how much do they really matter? In this piece, Arthur argues that the macro risk from the US-China trade conflict has ebbed to almost zero. What’s important now is to understand the dimensions of the decoupling between the world’s two biggest economies.

    1
  • Please login, request a trial or contact our sales team for more information

    Gavekal Dragonomics

    China And The US Still Hold The Keys To Markets' Fate

    In 2018 liquidity tightening in the US and China combined with trade war fears to make a miserable year for markets. In 2019 the same forces will be at work but the outcomes may differ. The key questions are: can the US and China work out a trade deal? How bad is the Chinese slowdown and how will Beijing respond? And how much will the Fed tighten?

    4
Show me: results